Increased CD8+CD28+ T cells independently predicted favorable OS and PFS in lung adenocarcinoma, while high levels of CD8+CD28- T cells predicted unfavorable OS and PFS in lung squamous cell carcinoma 32. The gene discussed is CD28; the disease is squamous cell lung carcinoma.